Unknown

Dataset Information

0

Matrix Metalloproteinase 8: Could it Benefit the CAR-T Cell Therapy of Solid Tumors?- a- Commentary on Therapeutic Potential.

ABSTRACT:

SUBMITTER: Mardomi A 

PROVIDER: S-EPMC6008262 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Matrix Metalloproteinase 8: Could it Benefit the CAR-T Cell Therapy of Solid Tumors?- a- Commentary on Therapeutic Potential.

Mardomi Alireza A   Abediankenari Saeid S  

Cancer microenvironment : official journal of the International Cancer Microenvironment Society 20180327 1

Similar Datasets

Unknown Current Clinical Evidence and Potential Solutions to Increase Benefit of CAR T-Cell Therapy for Patients with Solid Tumors.
| S-EPMC7466853 | biostudies-literature
Unknown Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.
| S-EPMC5621753 | biostudies-literature
Unknown Precision sniper for solid tumors: CAR-NK cell therapy.
| S-EPMC12290171 | biostudies-literature
Unknown Current Progress in CAR-T Cell Therapy for Solid Tumors.
| S-EPMC6854376 | biostudies-literature
Unknown CAR-NK cell therapy: promise and challenges in solid tumors.
| S-EPMC12009813 | biostudies-literature
Unknown CAR T cell therapy in solid tumors: a short review.
| S-EPMC8550638 | biostudies-literature
Unknown Clinical Investigations of CAR-T Cell Therapy for Solid Tumors.
| S-EPMC9339623 | biostudies-literature
Unknown Matrix Metalloproteinase 11 Is a Potential Therapeutic Target in Lung Adenocarcinoma.
| S-EPMC6477516 | biostudies-literature
Unknown Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors.
| S-EPMC12490251 | biostudies-literature
Unknown Hurdles to breakthrough in CAR T cell therapy of solid tumors.
| S-EPMC8974159 | biostudies-literature